Sign inJoin waitlistJoin the waitlist

SN

Sara Nunnery

Physician · OneOncology

Credentials: · · · ·

History

OneOncology
2024–Present

Vanderbilt University Medical Center
2019–2021
Internal Medicine
University of California-San Francisco
2016–2019
Univ of Tennessee Coll of Med
2012–2016

Research

Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
Review · Drugs · 2020 · First of 2 authors · 171 citations
Management of toxicity to isoform α-specific PI3K inhibitors
Review · Annals of Oncology · 2019 · First of 2 authors · 108 citations
Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma
Cancer · 2014 · 35 citations

George Yaghmour
5 papers · 5 as a fellow
Ingrid Mayer
5 papers
EW
Eric Wiedower
4 papers · 4 as a fellow
Smith Giri
4 papers · 4 as a resident
OJ
Omer Jamy
3 papers · 2 as a resident
BJ
Benny Johnson
2 papers · 2 as a fellow
JC
Jason Chandler
2 papers
Andrew Fintel
1 paper · 1 as a fellow
Andrew Hahn
1 paper · 1 as a resident
BY
Bassam Yaghmour
1 paper
Beth Kurt
1 paper
CI
Catherine Ireland
1 paper

Clinical trials

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2029
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Site PI · Recruiting · Phase 2
Dana-Farber Cancer Institute
2021–2029